Matthew Demelo

Matthew DeMelo, M.S., is an experienced professional in Quality Assurance, currently serving as Senior Quality Assurance Manager at Blueprint Medicines since July 2019, previously holding the title of Associate Director Quality Assurance. Matthew's extensive background includes roles as Quality Assurance Manager at Amgen, Quality Assurance Compliance Specialist III at Celldex Therapeutics, and Quality Assurance Compliance Specialist II at Biogen, among others. Matthew's expertise encompasses implementing Quality Systems, managing GMP compliance, performing audits, and writing critical quality documentation. Matthew holds a Master's degree in Quality Assurance from California State University-Dominguez Hills and additional qualifications in Nuclear Medicine Technology and Biology from UMass Chan Medical School and the University of Massachusetts Dartmouth, respectively.